This unique symposium focused on the integration of checkpoint inhibitors into general oncology practice is part of an integrated series during which invited nursing faculty members will present actual patient cases from their practices, along with patient-provided lifestyle footage of themselves carrying out daily functions. No didactic presentations will be included, although relevant clinical research and data slides will augment moderated panel discussions designed to assess optimal therapeutic and supportive care strategies for each case. The panel will feature both medical oncologist and nurse experts to ensure that diverse perspectives emerge.
Moderator:
Neil Love, MD
Faculty:
Marianne J Davies, DNP, ACNP-BC, AOCNP-BC
Assistant Professor
Oncology Nurse Practitioner
Yale Cancer Center
New Haven, Connecticut
Roy S Herbst, MD, PhD
Ensign Professor of Medicine (Oncology)
Professor of Pharmacology
Chief of Medical Oncology
Director, Thoracic Oncology Research Program
Associate Director for Translational Research
Yale Comprehensive Cancer Center
Yale School of Medicine
New Haven, Connecticut
Evan J Lipson, MD
Assistant Professor, Medical Oncology
Melanoma and Cancer Immunology Programs
Johns Hopkins University School of Medicine
The Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland
Virginia J Seery, MSN, RN, ANP-BC
Adult Nurse Practitioner
Cutaneous Oncology and Biologics Program
Beth Israel Deaconess Medical Center
Boston, Massachusetts Roy S Herbst, MD, PhD
Yale School of Medicine
New Haven, Connecticut
Evan J Lipson, MD
The Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland
Virginia Seery, NP
Beth Israel Deaconess Medical Center
Boston, Massachusetts
This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Genentech BioOncology, and Merck.
Please click here to register for this event.
